Incannex Healthcare IXHL
NASDAQ IXHL
$3.38 -0.06 (-1.75%)
At close: Aug 20, 2026 · 1:55 PM UTC

Incannex Healthcare (IXHL) Total Debt (2024 - 2025)

Incannex Healthcare (IXHL) posted Total Debt of $1.4 million for Q1 2025, down 62.92% sequentially from $3.8 million in Q4 2024.

Incannex Healthcare (IXHL) Total Debt (2024 - 2025) Analysis & Trends

Incannex Healthcare has reported Total Debt for 2 years, with the latest figure at $1.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - -5.81 Bn
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn 16.59 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn 9.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 31.47 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 13.35 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn -
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 3.92 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 760.00 Mn
10 Incannex Healthcare 41.74 Mn 41.74 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.40 Mn
Dec 31, 2024 3.77 Mn